Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Lantheus Holdings Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ironwood Pharmaceuticals Inc. June 16, 202695.2%
-
Ironwood Pharmaceuticals Inc. June 10, 202596.4%
-
Ironwood Pharmaceuticals Inc. June 21, 202492.1%
-
Ironwood Pharmaceuticals Inc. June 20, 202397.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Ironwood Pharmaceuticals Inc. | Grant or award | +63,481 | — | — |
| Jun 16, 2026 | Ironwood Pharmaceuticals Inc. | Open-market sale | −21,571 | $3.73 | $80,460 |
| May 14, 2026 | Lantheus Holdings Inc. | Grant or award | +4,137 | — | — |
| Jun 10, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
| Jun 9, 2025 | Lantheus Holdings Inc. | Open-market sale | −5,192 | $81.62 | $423,771 |
| May 14, 2025 | Lantheus Holdings Inc. | Grant or award | +2,537 | — | — |
| Jun 18, 2024 | Ironwood Pharmaceuticals Inc. | Grant or award | +24,311 | — | — |
| Jun 10, 2024 | Ironwood Pharmaceuticals Inc. | Open-market sale | −22,766 | $6.29 | $143,198 |
| May 28, 2024 | Lantheus Holdings Inc. | Open-market sale | −2,500 | $78.50 | $196,250 |
| May 9, 2024 | Lantheus Holdings Inc. | Grant or award | +2,635 | — | — |
| Jun 20, 2023 | Ironwood Pharmaceuticals Inc. | Grant or award | +22,350 | — | — |
| May 11, 2023 | Lantheus Holdings Inc. | Grant or award | +2,012 | — | — |
Questions about Julie McHugh
What boards is Julie McHugh on?
Julie McHugh sits on the boards of Ironwood Pharmaceuticals Inc. and Lantheus Holdings Inc.
How long has Julie McHugh served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.